oral liposomal glutathione bioavailability study Glutathione-Case oral glutathione bioavailability liposomal randomized

Vallieres, S.-Y.J

As the prevalence of T2DM increases globally and is recognized as a reemerging risk and challenge to manage TB, more research should investigate the possible benefits of using L-GSH as a potential adjunct therapy alongside current anti-TB treatments or even as a preventative strategy for individuals with T2DM with known dysregulation of GSH metabolism and increased oxidative stress

A standard dose is effective across a wide range of body sizes

This spatial metabolic heterogeneity confers marked differences in therapeutic responsiveness among cancer cells residing in distinct tumor niches

M.RahmanA.HasanuzzamanM.NaharK.FujitaM